Stay updated on the progress of our pioneering endeavors.
In October 2024, Lei Yunshang Pharmaceutical Group Co., Ltd. (“Lei Yunshang”), a time-honored company in traditional Chinese medicine (TCM), launched its highly anticipated Herbal Paste Festival.
On October 18, 2024, LUCI, China’s first adjustable intracranial stent retriever developed by Grand Pharma, received its medical device registration certificate from the China National Medical Products Administration (NMPA)
On October 18, 2024, the Nangang branch of Grand Shopping Center in Harbin, known as the City of Ice, hosted an exclusive appreciation event for its Platinum VIPs. The event drew significant anticipation, attracting a large crowd and creating a lively atmosphere.
On June 19, Sinclair Aesthetics (“Sinclair”) hosted a new product launch at the Shangri-La Hotel in Shanghai, featuring the debut of the second generation of ELLANSÉ® products, the “Regenerative Haute Series”, which included ELLANSÉ® Zhenyan™, ELLANSÉ® Jinyan™…
Grandpharma (China) Co., Ltd. (00512.HK) (hereinafter referred to as Grand Pharma) participated in the 5th World Health Expo (hereinafter referred to as the Health Expo) with heavy products on April 7th. At the Health Expo, a series of innovative medical products were unveiled, such as Yttrium-90…
On November 3rd, the Ministry of Industry and Information Technology of China announced the list of National Technology Innovation Demonstration Enterprises for 2022. Grand Pharmaceuticals (China) Co., Ltd. (hereinafter referred to as “Grand Pharma”) was honored and…